SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hideo Wada, Hidesaku Asakura, Kohji Okamoto, Toshiaki Iba, Toshimasa Uchiyama, Kazuo Kawasugi, Shin Koga, Toshihiko Mayumi, Kaoru Koike, Satoshi Gando, Shigeki Kushimoto, Yoshinobu Seki, Seiji Madoiwa, Ikuro Maruyama, Akira Yoshioka, Expert consensus for the treatment of disseminated intravascular coagulation in Japan, Thrombosis Research, 2010, 125, 1, 6

    CrossRef

  2. 2
    Satoshi Gando, Atsushi Sawamura, Mineji Hayakawa, Hirokatsu Hoshino, Nobuhiko Kubota, Akiko Oshiro, First day dynamic changes in antithrombin III activity after supplementation have a predictive value in critically ill patients, American Journal of Hematology, 2006, 81, 12
  3. 3
    Johannes N. Hoffmann, Dieter Mühlbayer, Marianne Jochum, Dietrich Inthorn, Effect of long-term and high-dose antithrombin supplementation on coagulation and fibrinolysis in patients with severe sepsis*, Critical Care Medicine, 2004, 32, 9, 1851

    CrossRef

  4. 4
    Marianne Nimah, Richard J Brilli, Coagulation dysfunction in sepsis and multiple organ system failure, Critical Care Clinics, 2003, 19, 3, 441

    CrossRef

  5. 5
    Schorr, Siebeck, Zügel, Welcker, Gippner-Steppert, Czwienzek, Gröschler, Jochum, Antithrombin III and local serum application: adjuvant therapy in peritonitis, European Journal of Clinical Investigation, 2000, 30, 4
  6. 6
    P. Danielsson, L. Nilsson, H. Nettelblad, F. Sjöberg, Is there a need for antithrombin III substitution early after burn injury?, Burns, 1997, 23, 4, 300

    CrossRef

  7. You have free access to this content7
    Arash Afshari, Jørn Wetterslev, Jesper Brok, Ann Merete Møller, Antithrombin III for critically ill patients, The Cochrane Library,